TABLE II.

Clinical characteristics: Part 2

Patient no.	FEV1 (% predicted)	FEV1/FVC ratio (%)	DLCO (% predict)	Complications	CT findings
1	113	108	70	ITP	Nodular opacities Ground-glass opacity Mediastinal lymphadenopathy
2	88	76	58	ITP AIHA	Nodular opacities
3	61 (before) 62 (after)	98	51	PNA Enteropathy	Nodular opacities Mediastinal lymphadenopathy Bronchiectasis
4	71	75	109	PNA ITP	Nodular opacities Mediastinal lymphadenopathy
5	71 (before) 72 (after)	104	77	PNA ITP	Nodular opacities Ground-glass opacity Mediastinal lymphadenopathy
6	91	107	NA	PNA ITP	Nodular opacities Mediastinal lymphadenopathy Bronchiectasis

Pulmonary function testing was conducted before biopsy. One patient, patient 6, did not have DLCO measured as part of preoperative evaluation. CT findings are provided retrospectively as diagnosed by attending radiologists.

AIHA, Autoimmune hemolytic anemia; FVC, forced vital capacity; ITP, immune thrombocytopenic purpura; PNA, pneumonia.